517 related articles for article (PubMed ID: 25627821)
1. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
[TBL] [Abstract][Full Text] [Related]
2. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1509-20. PubMed ID: 18367586
[TBL] [Abstract][Full Text] [Related]
3. Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose.
Gu Y; Ande SR; Mishra S
Arch Biochem Biophys; 2011 Jan; 505(1):98-104. PubMed ID: 20887712
[TBL] [Abstract][Full Text] [Related]
4. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
5. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose.
Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH
J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814
[TBL] [Abstract][Full Text] [Related]
6. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
7. Sustained Increases in Cardiomyocyte Protein
Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
[TBL] [Abstract][Full Text] [Related]
8. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcomic Profiling Identifies Widespread O-Linked β-N-Acetylglucosamine Modification (O-GlcNAcylation) in Oxidative Phosphorylation System Regulating Cardiac Mitochondrial Function.
Ma J; Liu T; Wei AC; Banerjee P; O'Rourke B; Hart GW
J Biol Chem; 2015 Dec; 290(49):29141-53. PubMed ID: 26446791
[TBL] [Abstract][Full Text] [Related]
10. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
[TBL] [Abstract][Full Text] [Related]
12. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation in Hyperglycemic Pregnancies: Impact on Placental Function.
Ning J; Yang H
Front Endocrinol (Lausanne); 2021; 12():659733. PubMed ID: 34140929
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria.
Banerjee PS; Ma J; Hart GW
Proc Natl Acad Sci U S A; 2015 May; 112(19):6050-5. PubMed ID: 25918408
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.
Clark RJ; McDonough PM; Swanson E; Trost SU; Suzuki M; Fukuda M; Dillmann WH
J Biol Chem; 2003 Nov; 278(45):44230-7. PubMed ID: 12941958
[TBL] [Abstract][Full Text] [Related]
16. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
17. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
18. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
Ngoh GA; Hamid T; Prabhu SD; Jones SP
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
20. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
